DG

Dilip Gopal Nevrekar

Active Director Director DIN 09728733
DIN 09728733 First appointment Sep 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value •••• Premium profile

About Dilip Gopal Nevrekar

Data last updated:

Dilip Gopal Nevrekar is a Director at Celagenex Research (India) Private Limited (since 2022). The company operates in Pharma. Celagenex Research (India) Private Limited reported revenue of ₹157 Cr (FY 2025).

DIN 09728733
Primary Designation Director
Industry Pharma
First Appointment 01 Sep 2022
Oldest Company Age 7 yrs
Largest company Celagenex Research (India) Private Limited · ₹157 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Sep 20222019₹157 Cr (FY 2025)Active

Board colleagues of Dilip Gopal Nevrekar

Directorship timeline

Open interactive timeline →
Celagenex Research (India) Private Limited
Premium access

Shareholding and investment profile for Dilip Gopal Nevrekar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dilip Gopal Nevrekar

Dilip Gopal Nevrekar currently holds 1 directorship: Celagenex Research (India) Private Limited (Director, since 01 Sep 2022, revenue ₹157 Cr (FY 2025)).

Dilip Gopal Nevrekar was first appointed on 01 Sep 2022 as Director at Celagenex Research (India) Private Limited.

The current boards of Dilip Gopal Nevrekar's companies include Rajaram Shriram Samant (Celagenex Research (India) Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available